Trial Details
RECRUITINGBasic Information
| Clinical ID | c517 |
|---|---|
| Identifier | NCT06498167 |
| Trial Title | Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Disease|Drug Side Effect|Drug Use|Adverse Drug Event|Adverse Drug Reaction|Safety Issues |
| Interventions | DRUG: Upadacitinib |
Participant Information
| Sponsor | Universidade do Porto |
|---|---|
| City | Porto |
| Country/Region | Portugal |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2024-07-01 |
|---|---|
| Primary Completion Date | 2024-10-31 |
| Completion Date | 2024-12-31 |